Tracking COVID-19 Vaccine Development Efforts Across the Globe

COVID-19 Vaccine Development Schedule
Includes vaccine candidates in phase 3 testing, use, or both as of Jan 26, 2021.
(AZLB=Anhui Zhifei Longcom Biopharmaceutical. nr=non-replicating.
RIBSP=Research Institute for Biological Safety Problems.
VLP=virus-like particle.)

The past year has seen the rapid global spread of SARS-CoV-2—the virus responsible for the ongoing COVID-19 pandemic. While non-pharmaceutical interventions have been the mainstay of epidemic control to date, vaccination is likely to constitute the definitive, long-term defence strategy against SARS-CoV-2 morbidity, mortality, and transmission, offering the best hope of a return to normal life.

The urgent need for effective vaccines has prompted vaccine developers to pivot towards COVID-19, resulting in rapid growth of preclinical candidates (appendix) and an accelerated vaccine development pipeline. In response to the unfolding pandemic and the extraordinary volume and pace of global vaccine research, we developed an online, interactive vaccine tracker hosted by the Vaccine Centre (VaC) at the London School of Hygiene and Tropical Medicine (LSHTM; London, UK). Launched in April 2020, this tracker aims to collate up-to-date information on all COVID-19 vaccine candidates from inception through to deployment, enabling policy makers, researchers, and the public to keep informed of the rapid developments.

The LSHTM VaC tracker is focused on presenting a comprehensive and up-to-date overview of the global vaccine landscape, provided in a user-friendly and engaging format. The landscape feature is updated weekly, collating information on all preclinical and clinical candidates from the WHO COVID-19 vaccine landscape and the Milken Institute’s tracker, as well as information provided directly by developers. An interactive timeline displays clinical trial dates and locations for each candidate, providing users with the option to subset vaccines by platform and development phase.

Authors credits: Madhumita Shrotri; Tui Swinnen; Beate Kampmann; Edward P K Parker
Please see the full text article and interactive chart courtesy of The Lancet.

Recommended Posts